Cancer Genetics (CGIX) Stock: To Present At Rodman & Renshaw


Cancer Genetics Inc (NASDAQ: CGIX) released some big news this morning. The company announced that it will soon be providing a presentation for investors. Of course it is highly advised that if you already do invest in, or are considering investing CGIX, that you pay close attention to this presentation.

CGIX To Present At Rodman & Renshaw

As mentioned above, Cancer Genetics announced early this morning that it intends to give a presentation to investors relatively soon. The company is a leader in enabling precision medicine for oncology through molecular markers and diagnostics. The presentation will be featured at the 19th Annual Rodman & Renshaw Global Investment Conference, which is sponsored by H.C. Wainwright & Co., LLC. The conference will be held from September 10th to September 12th at the Lotte New York Place Hotel in New York City.

During the presentation, Panna Sharma, CEO at CGIX, will be providing an overview of the company’s business. As a presenter at the Rodman & Renshaw Global Investment Conference, the company will have the ability to participate in one-on-one meetings with investors who are registered to attend the conference. The presentation will take place on Monday, September 11, 2017, at 3:25 p.m. Eastern Time. If you would like to listen in on the presentation, you can do so by clicking here.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on CGIX. In particular we’ll be following the presentation to be given at the Rodman & Renshaw Global Investment Conference and advise that all investors or potential investors in the company do the same. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required


Please enter your comment!
Please enter your name here